TYP Probiotic complex
TYP Probiotic complex, licence 80072959: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- TYP Pharmaceutical Ltd.
- NPN or DIN-HM
- 80072959
- Status
- Active licence
- Licence date
- 11 October 2016
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| 4-alpha-D-glucane glucanohydrolase Source : Aspergillus flavus var. oryzae - En entier | 34000.0 FCC DU | Not calculated |
| Lactobacillus rhamnosus Source : Cellule entière | 20.0 Milliards d'UFC | Not calculated |
| Lactobacillus rhamnosus Source : GG | 20.0 Milliards d'UFC | Not calculated |
| Triacylglycérol lipase Source : Aspergillus flavus var. oryzae - En entier | 12750.0 FCC NLU | Not calculated |
| Protéase Source : Aspergillus flavus var. oryzae - En entier | 2625.0 FCC HUT | Not calculated |
Non-medicinal ingredients
Maltodextrine, Stéarate de magnésium, Gélatine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1.0 Capsule | 1.0 Tous les jours |
Uses authorised in Canada
Helps support intestinal/gastrointestinal health. Could promote a favorable gut flora. Digestive enzymes.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
If you are pregnant or breastfeeding, consult a health care practitioner prior to use. If you have diabetes, consult a health care practitioner prior to use. If you have gastrointestinal lesions/ulcers, are taking anticoagulant agent or anti - inflammatory agent, or are having surgery, consult a health care practitioner prior to use. If symptoms of digestive upset occurs and persists beyond 3 days, discontinue use and consult a health care practitioner. Hypersensitivity has been known to occur; in which case, discontinue use. For prolonged use, consult a health care practitioner. If you have fever, vomiting, bloody diarrhoea or severe abdominal pain, consult a health care practitioner prior to use.
- Contre-indications
If you have an immune - compromised condition (e.g. AIDS, lymphoma, patients undergoing long - term corticosteroid treatment), do not use this product. If you are taking ampicillin, do not use this product.
Source
Official Health Canada record, licence 80072959
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.